- Report
- December 2024
- 1214 Pages
Global
From €1457EUR$1,684USD£1,200GBP
- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 192 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 141 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 146 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- October 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- December 2024
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 250 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- August 2024
- 200 Pages
Global
From €3465EUR$3,869USD£2,954GBP
- Report
- July 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- July 2024
- 157 Pages
Global
From €3807EUR$4,250USD£3,245GBP
- Report
- March 2025
- 140 Pages
Global
From €3910EUR$4,365USD£3,333GBP
€4344EUR$4,850USD£3,703GBP
- Report
- August 2024
- 110 Pages
Asia Pacific
From €4434EUR$4,950USD£3,779GBP
- Report
- May 2025
- 200 Pages
Europe
From €2230EUR$2,490USD£1,901GBP
- Report
- December 2022
- 409 Pages
Global
From €1214EUR$1,403USD£1,000GBP
- Report
- January 2023
- 242 Pages
Global
From €1214EUR$1,403USD£1,000GBP

The Wearable Cardioverter Defibrillator (WCD) is a type of cardiovascular device used to detect and treat life-threatening arrhythmias. It is worn on the body and is designed to detect and treat ventricular tachycardia and ventricular fibrillation. The device is typically used in patients who are at risk of sudden cardiac arrest, such as those with a history of heart failure or a previous cardiac arrest. It is also used in patients who have had an implantable cardioverter defibrillator (ICD) removed due to complications.
The WCD market is growing due to the increasing prevalence of cardiovascular diseases and the need for improved patient care. The device is also becoming more widely accepted due to its convenience and safety. Additionally, technological advancements have enabled the device to be more accurate and reliable.
Some of the major players in the WCD market include Medtronic, Abbott, Boston Scientific, Biotronik, and Zoll Medical. Show Less Read more